Expression of estrogen receptor subtypes and neuronal nitric oxide synthase in neutrophils from women and men: Regulation by estrogen

Cardiovascular Research

Volumn 56, Issue 1, 2002, Pages 43-51

  Molero, Laura ^a   García Durán, Margarita ^a   Diaz Recasens, Joaquin ^a   Rico, Luis ^a   Casado, Santos ^a   López Farré, Antonio ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Gender; Gene expression; Leukocyte; Nitric Oxide; Receptors

Indexed keywords

CURCUMIN; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NITRIC OXIDE SYNTHASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; MENSTRUAL CYCLE; NERVE CELL; NEUTROPHIL; OVULATION; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MALE; MENSTRUAL CYCLE; NEUTROPHILS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; RECEPTORS, ESTROGEN; SEX;

EID: 0036776207     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00505-9     Document Type: Article

References (41)

1. Isless C.G., Hole D.J., Hawthorne V.M., Lever A.F. Relation between coronary risk and coronary mortality in women of the Renfew and Paisley survey: comparison with men. Lancet. 339:1992;702-706.
2. Gordon T., Kannel W.B., Hjothand M.C., McNamara P.M. Menopause and coronary heart disease: the Framinghan study. Ann Intern Med. 89:1978;157-161.
3. Rosenberg L., Hennenkens C.H., Rosner B., et al. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol. 139:1981;47-51.
4. Stampfer M.J. A review of the epidemiology of postmenopausal estrogens and the risk of coronary heart disease. Sex steroids and the cardiovascular system. 1992;145-160 Springer, Berlin.
5. Grodstein F., Stampfer M.J., Manson J.E., et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. New Engl J Med. 335:1996;453-461.
6. + channels. J Am Coll Cardiol. 38:2001;906-915.
7. 2+ leading. J Am Coll Cardiol. 36:2000;948-952.
8. + channels in a gender-dependent manner. Mech Ageing Dev. 123:2002;695-705.
9. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. New Engl J Med. 340:1999;1801-1811.
10. Cowley S.M., Hoare S., Mosselman S., Parker M.G. Estrogen receptors α and β form heterodimers on DNA. J Biol Chem. 272:1997;19858-19862.
11. Klebanoff S.J. Estrogen binding by leukocytes during phagocytosis. J Exp Med. 145:1977;983-998.
12. García-Durán M., de Frutos T., Diaz-Recasens J., et al. Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils. Circ Res. 85:1999;1020-1026.
13. García-Durán M., Galvez G., de Frutos T., Diaz Recasens J., Casado S., López-Farré A. 17beta-Estradiol stimulated nitric oxide production by neutrophils: Effect on platelet activation. Obstet Gynecol. 95:2000;284-290.
14. Prins G.S., Birch L. Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology. 138:1997;1801-1809.
15. Ing N.H., Tomesi M.B. Estradiol up-regulates estrogen receptor and progesterone receptor gene expression in specific ovine uterine cells. Biol Reprod. 56:1997;1205-1215.
16. Ing N.H., Spencer T.E., Bazer F.W. Estrogen enhances endometrial estrogen receptor gene expression by a posttranscriptional mechanism in the ovoriectomized ewe. Biol Reprod. 54:1996;591-599.
17. Saceda M., Lippman M.E., Lindsey R.K., Puente M., Martin M.B. Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. Mol Endocrinol. 3:1989;1782-1787.
18. Zon K., Ing N.H. Oestradiol up-regulates oestrogen receptor, cyclophilin and glyceraldehyde phosphate dehydrogenase mRNA concentrations in endometrium but down-regulates them in liver. J Steroid Biochem Mol Biol. 64:1998;231-237.
19. Fostermann U., Boissel J.P., Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOSI and NOSIII). FASEB J. 12:1998;773-790.
20. Webb P., Nguyen P., Valentine C., et al. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol. 13:1999;1672-1685.
21. Xie W., Duan R., Safe S. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions. Endocrinology. 40:1999;219-227.
22. Poter W., Saville B., Hoivik D., Safe S. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol. 11:1997;1569-1580.
23. López-Farré A., Caramelo C., Esteban A., et al. Effect of aspirin on platelet neutrophil interactions: role of nitric oxide and endothelin-1. Circulation. 96:1995;2795-2801.
24. López-Farré A., Riesco A., Digiuni E., et al. Aspirin-stimulated nitric oxide production by neutrophils after acute myocardial ischemia in rabbits. Circulation. 94:1996;83-87.
25. Laemmli N.K. Change of structural protein during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
26. Jimenez A., Arriero M.M., López-Blaya A., et al. Regulation of endothelial nitric oxide synthase expression in the vascular wall and in mononuclear cells from hypercholesterolemic rabbits. Circulation. 104:2001;1822-1830.
27. Arriero M M., Rodríguez-Feo J.A., Celdrán A., et al. Expression of endothelial nitric oxide synthase in human peritoneal tissue: regulation by E. coli lipopolysacharide. J Am Soc Nephrol. 11:2000;1848-1856.
28. Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilson S., Gustarsson J.A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 93:1996;5925-5930.
29. Sanchez de Miguel L., de Frutos T., Gonzalez-Fernandez F., et al. Aspirin inhibits inducible nitric oxide synthase expression and tumor necrosis factor-alpha release by cultured smooth muscle cells. Eur J Clin Invest. 29:1999;93-99.
30. Alonso J., Sanchez de Miguel L., Montón M., Casado S., López-Farré A. Endothelial cytosolic proteins bind to the 3′-untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis alpha. Mol Cell Biol. 17:1997;5719-5726.
31. Greenwel P., Inagaki Y., Hu W., Walsh M., Ramirez F. Sp-1 is required for the early response of alpha 2 (I) collagen to transforming growth factor-beta-1. J Biol Chem. 272:1997;19738-19745.
32. Zhang F., Altorki N.K., Mestre J.R., Subbaramaiah K., Dannenberg A.J. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and pharbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis. 20:1999;445-451.
33. McClelland R.A., Manning D.L., Gee J.M., et al. Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes. Breast Cancer Res Treat. 41:1996;31-41.
34. Sudhir K., Chou T.M., Messina L.M., et al. Endothelial dysfunction in a man with disrupted mutation in oestrogen-receptor gene. Lancet. 349:1997;1146-1147.
35. Plochocka-Zulinka D., Krukoff T.L. Increased gene expression of neuronal nitric oxide synthase in brain of adult spontaneously hypertensive rats. Mol Brain Res. 48:1997;291-297.
36. Tang Z., Treilleux I., Brown M. A transcriptional enhancer required for the different expression of the human estrogen receptor in breast cancer. Mol Cell Biol. 17:1997;1274-1280.
37. Zhu Y., Brian Z., Lu P., et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor β Science. 295:2002;505-508.
38. Sudhir K., Chon T.M., Chatlerjee K., et al. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation. 96:1997;3774-3777.
39. Grodstein F., Manson J.E., Colditz G.A., et al. A prospective observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 133:2000;933-941.
40. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post menopausal women. J. Am. Med. Assoc. 280:1998;605-613.
41. Manson J.E., Martin K.A. Postmenopausal hormone-replacement therapy. New Engl J Med. 345:2001;34-40.